SCHEMBL691981

SCHEMBL691981

NC(=O)C=CCc1cccc(Nc2cc(Nc3ccc(Oc4ccccc4)cc3)ncn2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.42
ERBB3 P21860 5/20 0.42
MEN1 O00255 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KMT2A Q03164 2/20 0.41
ABL1 P00519 3/20 0.41
BCR P11274 3/20 0.41
SCN9A Q15858 3/20 0.39
ERBB2 P04626 4/20 0.39
JAK3 P52333 2/20 0.39
ERBB4 Q15303 2/20 0.39
MAP3K7 O43318 1/20 0.38
TAB1 Q15750 1/20 0.38
CDK4 P11802 1/20 0.38
BTK Q06187 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
SCN5A Q14524 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL691980 0.77 EGFR (0.48) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL691983 0.77 EGFR (0.48) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL12262446 0.76 SCN9A (0.64) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL691982 0.75 MTNR1A (0.51) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL12262344 0.75 EGFR (0.57) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL12282836 0.75 EGFR (0.53) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL691611 0.75 EGFR (0.64) EGFRERBB3ERBB2JAK3ERBB4
SCHEMBL691610 0.75 EGFR (0.64) EGFRERBB3ERBB2JAK3ERBB4
SCHEMBL2203988 0.73 EGFR (0.53) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL2203981 0.73 EGFR (0.53) EGFRERBB3MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421538-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-02-29 EP disclosed
WO-2010123870-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-10-28 WO disclosed